SalioGen Therapeutics logo

SalioGen Therapeutics

Accelerating the impact of genetic medicines for patients with Gene Coding™ technology

55 employees · est. 2020 · Lexington, United States

VS
Tune Therapeutics logo

Tune Therapeutics

Mastering the epigenome, unlocking complex disease.

67 employees · est. 2020 · Seattle, United States

Side-by-Side Comparison

SalioGen Therapeutics Tune Therapeutics
Founded
2020 2020
Headquarters
Lexington, United States Seattle, United States
Employees
55 67
Industry
Not tracked yet Biotechnology
Funding Stage
Unknown Series B
Total Funding
$135.00M $215.00M
Funding Rounds
2 2
Services
genetic medicine development, biotechnological research, gene modification Epigenetic silencing for diseases like Hepatitis B, Regulation of gene activity without altering DNA sequence, Developing gene, cell, and regenerative therapies
Target Customers
medical researchers, biotech firms, healthcare providers Healthcare providers, Biotech researchers, Patients with chronic or age-related diseases, Clinical trial participants
Taxonomy
Genetic Medicine, Gene Coding Technology, Non-Viral Gene Integration, EDIT Platform, Stargardt Disease, Cystic Fibrosis, Inherited Retinal Diseases, CAR-T Cell Engineering, Genome Engineering, Saliogase Enzymes, Genetic Therapy, Cell Therapy Development, Inherited Disorder Treatments, Gene Therapy Manufacturing, Cancer And Autoimmune Conditions Epigenomics, Epigenetic Programming, Epi-therapeutic Medicines, Gene Expression Modulation, Cell Fate Modulation, Genetic Medicine, Cancer Therapeutics, Genetic Disease Treatment, Aging Reversal Therapies, Complex Disease Treatment, Cell Therapy, Gene Therapy, Biotechnology Innovation, Temporal Gene Expression Control, Precision Medicine
Website
saliogen.com tunetx.com
SalioGen Therapeutics logo

About SalioGen Therapeutics

SalioGen Therapeutics is a cutting-edge biotechnology firm, founded in 2020, headquartered in the United States. The company is dedicated to pioneering advancements in genetic medicine through its innovative Gene Coding™ technology. This proprietary method offers a non-viral approach to gene integra...

Tune Therapeutics logo

About Tune Therapeutics

Tune Therapeutics, with its slogan "Mastering the epigenome, unlocking complex disease," is making significant strides in the biotechnology industry since its founding in 2020. Headquartered in the United States, the company is at the forefront of epi-therapeutic medicine development. Its proprietar...

We will tell you when either one moves

BounceWatch watches SalioGen Therapeutics and Tune Therapeutics for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at SalioGen Therapeutics and Tune Therapeutics — by email.

Frequently Asked Questions

SalioGen Therapeutics — Accelerating the impact of genetic medicines for patients with Gene Coding™ technology. Tune Therapeutics — Mastering the epigenome, unlocking complex disease.. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
SalioGen Therapeutics has raised $135.00M while Tune Therapeutics has raised $215.00M.
SalioGen Therapeutics and Tune Therapeutics operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare SalioGen Therapeutics with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at SalioGen Therapeutics on 28 Jan 2026, and Tune Therapeutics on 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes